Disease modifying therapies in multiple sclerosis

Neurology. 2002 Aug 13;59(3):471-2; author reply 472-3. doi: 10.1212/wnl.59.3.471.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Humans
  • Interferon beta-1a
  • Interferon-beta / therapeutic use
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / pathology

Substances

  • Adjuvants, Immunologic
  • Interferon-beta
  • Interferon beta-1a